{"id":5479,"date":"2026-01-17T01:06:28","date_gmt":"2026-01-16T22:06:28","guid":{"rendered":"https:\/\/dmdwarrior.com\/?p=5479"},"modified":"2026-01-17T01:06:30","modified_gmt":"2026-01-16T22:06:30","slug":"atossa-therapeutics-receives-fda-orphan-drug-designation-for-z-endoxifen-for-the-treatment-of-duchenne-muscular-dystrophy","status":"publish","type":"post","link":"https:\/\/dmdwarrior.com\/ar\/atossa-therapeutics-receives-fda-orphan-drug-designation-for-z-endoxifen-for-the-treatment-of-duchenne-muscular-dystrophy\/","title":{"rendered":"\u062d\u0635\u0644 \u0627\u0644\u0645\u0631\u0643\u0628 Atossa Therapeutics \u0639\u0644\u0649 \u062a\u0635\u0646\u064a\u0641 \u062f\u0648\u0627\u0621 \u0627\u0644\u064a\u062a\u064a\u0645 FDA \u0644\u0639\u0644\u0627\u062c \u0636\u0645\u0648\u0631 \u062f\u0648\u0634\u064a\u0646 \u0627\u0644\u0639\u0636\u0644\u064a (Z)-Endoxifen"},"content":{"rendered":"<p class=\"wp-block-paragraph\">\u0623\u0639\u0644\u0646\u062a \u0634\u0631\u0643\u0629 Atossa Therapeutics \u0623\u0646 \u0645\u0643\u062a\u0628 \u062a\u0637\u0648\u064a\u0631 \u0627\u0644\u0645\u0646\u062a\u062c\u0627\u062a \u0627\u0644\u064a\u062a\u064a\u0645\u0629 \u0627\u0644\u062a\u0627\u0628\u0639 \u0644\u0625\u062f\u0627\u0631\u0629 \u0627\u0644\u063a\u0630\u0627\u0621 \u0648\u0627\u0644\u062f\u0648\u0627\u0621 \u0627\u0644\u0623\u0645\u0631\u064a\u0643\u064a\u0629 (FDA) \u0642\u062f \u0645\u0646\u062d \u062a\u0635\u0646\u064a\u0641 \u062f\u0648\u0627\u0621 \u064a\u062a\u064a\u0645 \u0644\u0644\u062f\u0648\u0627\u0621 (Z)-endoxifen \u0644\u0639\u0644\u0627\u062c \u0636\u0645\u0648\u0631 \u062f\u0648\u0634\u064a\u0646 \u0627\u0644\u0639\u0636\u0644\u064a (DMD). <strong>\u064a\u062a\u0639\u0644\u0645 \u0623\u0643\u062b\u0631:<\/strong> <a href=\"https:\/\/dmdwarrior.com\/ar\/atossa-therapeutics-receives-fda-rare-pediatric-disease-designation-for-z-endoxifen-for-duchenne-muscular-dystrophy\/\" target=\"_blank\" data-type=\"link\" data-id=\"https:\/\/dmdwarrior.com\/atossa-therapeutics-receives-fda-rare-pediatric-disease-designation-for-z-endoxifen-for-duchenne-muscular-dystrophy\/\" rel=\"noreferrer noopener\">\u062d\u0635\u0644 \u0627\u0644\u0645\u0631\u0643\u0628 Atossa Therapeutics \u0639\u0644\u0649 \u062a\u0635\u0646\u064a\u0641 FDA \u0644\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0646\u0627\u062f\u0631\u0629 \u0644\u062f\u0649 \u0627\u0644\u0623\u0637\u0641\u0627\u0644 (Z)-Endoxifen<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u201c&quot;\u0628\u0627\u0644\u0625\u0636\u0627\u0641\u0629 \u0625\u0644\u0649 \u062a\u0635\u0646\u064a\u0641 \u0645\u0631\u0636 \u0627\u0644\u0623\u0637\u0641\u0627\u0644 \u0627\u0644\u0646\u0627\u062f\u0631 \u0627\u0644\u0630\u064a \u062a\u0645 \u0627\u0644\u062d\u0635\u0648\u0644 \u0639\u0644\u064a\u0647 \u0633\u0627\u0628\u0642\u064b\u0627\u060c \u0641\u0625\u0646 \u062a\u0635\u0646\u064a\u0641 \u062f\u0648\u0627\u0621 \u0627\u0644\u064a\u062a\u064a\u0645 \u0644\u0640 (Z)-endoxifen \u0641\u064a \u0636\u0645\u0648\u0631 \u062f\u0648\u0634\u064a\u0646 \u0627\u0644\u0639\u0636\u0644\u064a \u064a\u0645\u062b\u0644 \u0639\u0644\u0627\u0645\u0629 \u0641\u0627\u0631\u0642\u0629 \u0645\u0647\u0645\u0629 \u0644\u0640 Atossa \u0628\u064a\u0646\u0645\u0627 \u0646\u0645\u0636\u064a \u0642\u062f\u0645\u064b\u0627 \u0641\u064a \u062a\u0637\u0648\u064a\u0631 (Z)-endoxifen \u0644\u0647\u0630\u0627 \u0627\u0644\u0645\u0631\u0636 \u0627\u0644\u062e\u0637\u064a\u0631 \u0648\u0627\u0644\u0645\u064f\u0646\u0647\u0643&quot;\u060c \u0643\u0645\u0627 \u0623\u0634\u0627\u0631 \u0633\u062a\u064a\u0641\u0646 \u0633\u064a. \u0643\u0648\u0627\u064a\u060c \u0627\u0644\u062d\u0627\u0635\u0644 \u0639\u0644\u0649 \u062f\u0643\u062a\u0648\u0631\u0627\u0647 \u0641\u064a \u0627\u0644\u0637\u0628\u060c \u0631\u0626\u064a\u0633 \u0645\u062c\u0644\u0633 \u0627\u0644\u0625\u062f\u0627\u0631\u0629 \u0648\u0627\u0644\u0631\u0626\u064a\u0633 \u0627\u0644\u062a\u0646\u0641\u064a\u0630\u064a \u0644\u0634\u0631\u0643\u0629 Atossa Therapeutics.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">\u062a\u062e\u0637\u0637 Atossa \u0644\u0645\u0648\u0627\u0635\u0644\u0629 \u0627\u0644\u062a\u0639\u0627\u0648\u0646 \u0645\u0639 FDA \u0623\u062b\u0646\u0627\u0621 \u062a\u0642\u062f\u0645 \u062c\u0647\u0648\u062f \u0627\u0644\u062a\u0637\u0648\u064a\u0631 \u0648\u0633\u062a\u0642\u062f\u0645 \u062a\u062d\u062f\u064a\u062b\u0627\u062a \u062d\u0633\u0628 \u0627\u0644\u0627\u0642\u062a\u0636\u0627\u0621.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>\u062a\u0627\u0628\u0639 \u0647\u0630\u0647 \u0627\u0644\u0635\u0641\u062d\u0629<\/strong>&nbsp;&gt;&gt;&gt;&nbsp;<a href=\"https:\/\/dmdwarrior.com\/ar\/dmd-therapies\/\" target=\"_blank\" rel=\"noreferrer noopener\">\u062c\u0645\u064a\u0639 \u0627\u0644\u062a\u062c\u0627\u0631\u0628 \u0627\u0644\u0633\u0631\u064a\u0631\u064a\u0629 \u0644\u0645\u0631\u0636 \u062f\u0648\u0634\u064a\u0646<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Atossa Therapeutics, announced that the U.S. Food and Drug Administration (&#8220;FDA&#8221;) Office of Orphan Products Development has granted Orphan Drug Designation to (Z)-endoxifen for the treatment of Duchenne muscular dystrophy (&#8220;DMD&#8221;). >> Learn More: Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen &#8220;In addition to the previously received Rare Pediatric Disease designation, Orphan [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":5480,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[281],"tags":[461,462,464,463],"class_list":["post-5479","post","type-post","status-publish","format-standard","has-post-thumbnail","category-press-releases","tag-z-endoxifen","tag-atossa-therapeutics","tag-endoxifen","tag-tamoxifen"],"_links":{"self":[{"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/posts\/5479","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/comments?post=5479"}],"version-history":[{"count":0,"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/posts\/5479\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/media\/5480"}],"wp:attachment":[{"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/media?parent=5479"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/categories?post=5479"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dmdwarrior.com\/ar\/wp-json\/wp\/v2\/tags?post=5479"}],"curies":[{"name":"\u0648\u0648\u0631\u062f\u0628\u0631\u064a\u0633","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}